z-logo
open-access-imgOpen Access
Melanoma therapeutics: a literature review
Author(s) -
Pavan Kumar Dhanyamraju,
Trupti Patel
Publication year - 2022
Publication title -
journal of biomedical research/journal of biomedical research
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2352-4685
pISSN - 1674-8301
DOI - 10.7555/jbr.36.20210163
Subject(s) - melanoma , medicine , immunotherapy , cancer , skin cancer , oncology , bioinformatics , cancer research , biology
Melanoma is a relentless type of skin cancer which involves myriad signaling pathways which regulate many cellular processes. This makes melanoma difficult to treat, especially when identified late. At present, therapeutics include chemotherapy, surgical resection, biochemotherapy, immunotherapy, photodynamic and targeted approaches. These interventions are usually administered as either a single-drug or in combination, based on tumor location, stage, and patients' overall health condition. However, treatment efficacy generally decreases as patients develop treatment resistance. Genetic profiling of melanocytes and the discovery of novel molecular factors involved in the pathogenesis of melanoma have helped to identify new therapeutic targets. In this literature review, we examine several newly approved therapies, and briefly describe several therapies being assessed for melanoma. The goal is to provide a comprehensive overview of recent developments and to consider future directions in the field of melanoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here